Article Details
Retrieved on: 2021-06-29 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... company that acquired exclusive worldwide rights to CLN-619, which was discovered by PDI Therapeutics, a portfolio company of Avalon Ventures.
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here